These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30233409)

  • 1. RXFP1 Receptor Activation by Relaxin-2 Induces Vascular Relaxation in Mice
    Lian X; Beer-Hammer S; König GM; Kostenis E; Nürnberg B; Gollasch M
    Front Physiol; 2018; 9():1234. PubMed ID: 30233409
    [No Abstract]   [Full Text] [Related]  

  • 2. Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment.
    Jelinic M; Leo CH; Post Uiterweer ED; Sandow SL; Gooi JH; Wlodek ME; Conrad KP; Parkington H; Tare M; Parry LJ
    FASEB J; 2014 Jan; 28(1):275-87. PubMed ID: 24036884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.
    McGuane JT; Debrah JE; Sautina L; Jarajapu YP; Novak J; Rubin JP; Grant MB; Segal M; Conrad KP
    Endocrinology; 2011 Jul; 152(7):2786-96. PubMed ID: 21558316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.
    Conrad KP
    Hum Reprod Update; 2016 Sep; 22(5):647-64. PubMed ID: 27385360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
    Halls ML; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
    Halls ML; Bathgate RA; Summers RJ
    Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazine herbicides inhibit relaxin signaling and disrupt nitric oxide homeostasis.
    Park SE; Lim SR; Choi HK; Bae J
    Toxicol Appl Pharmacol; 2016 Sep; 307():10-18. PubMed ID: 27431321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta.
    Ng HH; Leo CH; Parry LJ
    Pharmacol Res; 2016 May; 107():220-228. PubMed ID: 26993102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes.
    Peixoto P; Aires RD; Lemos VS; Bissoli NS; Santos RLD
    Life Sci; 2017 Aug; 183():21-27. PubMed ID: 28645860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin).
    Leo CH; Jelinic M; Ng HH; Tare M; Parry LJ
    Br J Pharmacol; 2016 Mar; 173(6):1005-17. PubMed ID: 26660642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
    Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
    Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
    Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
    Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2.
    Mookerjee I; Hewitson TD; Halls ML; Summers RJ; Mathai ML; Bathgate RA; Tregear GW; Samuel CS
    FASEB J; 2009 Apr; 23(4):1219-29. PubMed ID: 19073841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.
    Samuel CS; Du XJ; Bathgate RA; Summers RJ
    Pharmacol Ther; 2006 Nov; 112(2):529-52. PubMed ID: 16814863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
    Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
    Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
    Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
    Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
    Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
    J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding relaxin signalling at the cellular level.
    Valkovic AL; Bathgate RA; Samuel CS; Kocan M
    Mol Cell Endocrinol; 2019 May; 487():24-33. PubMed ID: 30592984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice.
    Segal MS; Sautina L; Li S; Diao Y; Agoulnik AI; Kielczewski J; McGuane JT; Grant MB; Conrad KP
    Blood; 2012 Jan; 119(2):629-36. PubMed ID: 22028476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290.
    Kaftanovskaya EM; Soula M; Myhr C; Ho BA; Moore SN; Yoo C; Cervantes B; How J; Marugan J; Agoulnik IU; Agoulnik AI
    J Endocr Soc; 2017 Jun; 1(6):712-725. PubMed ID: 28825052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.